Disclosed in certain embodiments is a compound of Formula I: X-Z (I) wherein X is a monosugar or disugar moiety and Z is a C8-20 straight chain alkyl, alkenyl or alkynyl having 1-5 substituents (Y) on the first 6 carbons proximal to the disugar moiety, wherein each Y is independently C1-8 linear alkyl, C3-8 branched alkyl, C3-8 cycloalkyl, halogen, hydroxyl, monocyclic aromatic, monocyclic heteroaromatic, bicyclic aromatic, bicyclic heteroaromatic, tricyclic aromatic, or tricyclic heteroaromatic, wherein each Y is independently optionally substituted with C1-8 linear alkyl, C3-8 branched alkyl, C3-8 cycloalkyl, halogen or hydroxyl and pharmaceutical compositions and methods thereof.
在某些实施例中,公开了一种式子为X-Z(I)的化合物,其中X是
单糖或
双糖基团,Z是具有1-5个取代基(Y)的C8-20直链烷基,烯基或炔基,这些取代基位于靠近
双糖基团的前6个碳上,其中每个Y独立地是C1-8线性烷基,C3-8支链烷基,C3-8环烷基,卤素,羟基,单环芳香族,单环杂芳香族,双环芳香族,双环杂芳香族,
三环芳香族或
三环杂芳香族,其中每个Y独立地可以用C1-8线性烷基,C3-8支链烷基,C3-8环烷基,卤素或羟基进行取代,以及其制备的药物组合物和方法。